Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic adjustable gastric band and port device 
placement

 
History of Present Illness:
Per Dr. ___ has class III morbid obesity with 
weight of 242.1 lbs as of ___ with her screen weight of 241.3 
lbs on ___, height of 63.5 inches and BMI of 42.2. Her 
initial screen weight ___ was 234.2 lbs and BMI of 39. Her 
previous weight loss efforts have ___ diet, 
Slim-Fast, prescription weight loss medication phentermine and 
self-initiated diets losing up to only 10 lbs but unable to 
maintain. She stated that she has weighed
between 230 to 240 lbs over the past ___ years and has been 
struggling with weight since age ___ citing as factors 
contributing to her excess weight large portions, too many 
carbohydrates, convenience eating and lack of exercise regimen. 
She does walk her dog at fast pace for 20 minutes twice daily 
that she has been doing so for ___ years. She denied history of 
eating disorders - no anorexia, bulimia, diuretic or laxative 
abuse and she denied binge eating. She does not have a clinical 
diagnosis of depression and has not seen a therapist nor has she 
been hospitalized for mental health issues and she is not on any
psychotropic medications.
 
Past Medical History:
1)  polycystic ovary syndrome
2)  infertility
3)  hepatic steatosis by ultrasound study
4)  vitamin D deficiency
5)  iron deficiency with saturation of 13.5%
6)  hyperuricemia

Her surgeries include:

1)  tonsillectomy
2)  wisdom teeth extraction
 
Social History:
___
Family History:
Her family history is noted for both parents living father age 
___ with diabetes; mother age ___ with obesity s/psleeve 
gastrectomy, history of stroke and diabetes; 2 brothers alive 
and well as well as 3 sisters alive and well.
 
Physical Exam:
T 97.6 P 62 BP 97/67 RR 18 02 96%RA
Gen: no acute distress
Cardiac: regular rhythm, no murmurs, NL S1,S2
Resp: clear to auscultation, bilaterally
Abd: soft, appropriately tender to palpation without rebound 
tenderness or guarding
Wounds: abdominal lap sites with primary dsg, no periwound 
erythema
Ext: no lower extremity edema or tenderness, bilaterally
 
Pertinent Results:
___ 07:49AM BLOOD Hct-35.9
 
Brief Hospital Course:
The patient presented to pre-op on ___. Pt was 
evaluated by anaesthesia and taken to the operating room where 
she underwent a laparoscopic adjustable gastric band and port 
placement. There were no adverse events in the operating room; 
please see the operative note for details. Pt was extubated, 
taken to the PACU until stable, then transferred to the ward for 
observation. 

Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with oral oxycodone 
and then transitioned to oral hydrocodone-acetaminophen.  
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization. 
GI/GU/FEN: On POD1, an UGI series confirmed appropriate band 
placement, therefore, the diet was progressed from stage 1 to 
stage 3 and was well tolerated. Patient's intake and output were 
closely monitored.  
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.
HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.
Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. ferrous sulfate 134 mg (27 mg iron) oral DAILY 
2. Multivitamins 1 TAB PO DAILY 
3. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Medications:
1.  Docusate Sodium 100 mg PO BID:PRN constipation 
RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp 
#*30 Tablet Refills:*0 
2.  Famotidine 20 mg PO BID 
please crush 
RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
3.  HYDROcodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H:PRN 
Pain - Moderate 
  Reason for PRN duplicate override: change of meds
RX *hydrocodone-acetaminophen 5 mg-300 mg ___ tablet(s) by mouth 
every four (4) hours Disp #*30 Tablet Refills:*0 
4.  ferrous sulfate 134 mg (27 mg iron) oral DAILY  
5.  Multivitamins 1 TAB PO DAILY  
6.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Discharge Instructions: Please call your surgeon or return to 
the Emergency Department if you develop a fever greater than 101 
F, shaking chills, chest pain, difficulty breathing, pain with 
breathing, cough, a rapid heartbeat, dizziness, severe abdominal 
pain, pain unrelieved by your pain medication, a change in the 
nature or severity of your pain, severe nausea, vomiting, 
abdominal bloating, severe diarrhea, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness, 
swelling from your incisions, or any other symptoms which are 
concerning to you.

Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  

Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___